Rising Geriatric Population Driving Wearable Injectors Market

Posted by Pramod Arya on April 20th, 2022

The global wearable injectors market is predicted to register significant growth in the coming years. This is attributed to the increasing demand for advanced drug delivery, rising geriatric population, and surging prevalence of chronic diseases. A device which is utilized for delivering large volume of drugs over an extended period of time is referred to as a wearable injector. The device delivers large subcutaneous doses of drugs to patients even when the patient is ambulatory and is able to carry out normal daily life activities during the drug delivery.

When type is taken into consideration, the wearable injectors market is divided into bolus injector, body-worn patch injector, and off-body worn belt injector. Among these, the body-worn patch injector division held the largest share of the market in the past, however, the bolus injector division is projected to dominate the market in the near future. This is because of the ability of bolus injector to treat several diseases including auto-immune diseases, blood disorders, cancer, infectious diseases, and cardiovascular diseases. The division is further projected to grow at the fastest pace in the coming years.

In terms of end user, the wearable injectors market is categorized into lab & diagnostics, home care, hospital, and others (which include small clinics and healthcare settings). Out of these, the home care category dominated the market in the past and is expected to account for the major share of the market in the near future as well due to the growing demand for self-injection system. On the basis of technology, the market is classified into mechanical injector, electronic injector, and others (which include hydrogel and hydraulic injector).

The increasing adoption of wearable injectors in developing countries is opening up wide opportunities for the players operating in the wearable injectors market. This is ascribed to the rising awareness regarding the availability of these devices and increasing healthcare spending. In addition to this, the prevalence of chronic diseases is high in emerging economies, such as Brazil, India, and China, because of a lack of healthcare awareness, which is further creating an increased demand for these devices. As per the International Diabetes federation, China has the largest population of adults suffering from diabetes.
Hence, the market is being driven by the increasing geriatric population and rising need for advanced drug delivery